The Immunotherapy Study

Closing Soon

5 Nov to 9 Nov 2025

Up to $5,250

We’re testing a potential new treatment designed to help people living with conditions where the immune system mistakenly attacks the body’s own cells. This study aims to better understand how the therapy interacts with the immune system and whether it can help reduce unwanted immune responses.

Apply now Speak with us

Join our clinical trial

This trial has been carefully designed with strict safety protocols. Before participating, you will be given detailed information about the study, its procedures, and how risks are managed. You’ll also meet with one of our doctors to discuss any questions you may have. 

Nucleus Network - Image

Why participate?

By participating, you’ll contribute to research that could inform future care for a wide range of autoimmune diseases. 

  • Help researchers develop better autoimmunity solutions for everyone. 
  • By participating, you’re helping pave the way for others living with autoimmune conditions—your role could help improve care for generations to come. 

 

Trial details

Study medication

Administered through either a subcutaneous injection, or IV depending on your cohort. 

Ethics

An independent ethics committee has approved this clinical trial. 

Additional eligibility

  • Weight between 45kg and 110kg 
  • Healthy with no significant medical history 
  • Not currently taking other diabetes or weight loss medications
  • Must be willing to adhere to contraception requirements as informed by our medical team 
  • Non-smoker or smoking no more than 2 cigarettes per day 
  • 2025 Influenza vaccine and COVID-19 booster within 12 months prior to dosing required (or willing to receive)

Study duration

4-night stay and 5 follow-up visits

Are you a match?

Age

18 - 60 years old

Remuneration

Up to $5,250 *with screening reimbursement. Please see T&Cs.

Gender

Male or Female

BMI

BMI 18 - 32 kg/m2

Commitment

4 nights, 5 clinic visits

Register Your Interest

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We regularly have studies that allow participants who are (social) smokers.

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Preferences

While longer studies generally have a higher reimbursement, there are also studies with multiple short stays that have high reimbursements.
Referral Information



Consent to Information Use and Future Contact